| ACC | Adrenocortical Carcinoma |
| AUC | Area Under Curve |
| BLCA | Bladder Urothelial Carcinoma |
| BRCA | Breast Invasive Carcinoma |
| CESC | Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
| CHOL | Cholangiocarcinoma |
| COAD | Colon Adenocarcinoma |
| DEGs | Differentially Expressed Genes |
| DLBC | Lymphoid Neoplasm Diffuse Large B-Cell Lymphoma |
| DRGs | Disulfidptosis-Related Genes |
| DRLs | Disulfidptosis-Related LncRNAs |
| ESCA | Esophageal Carcinoma |
| GBM | Glioblastoma Multiforme |
| GO | Gene Ontology |
| GSEA | Gene Set Enrichment Analysis |
| HNSCC | Head and Neck Squamous Cell Carcinoma |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| KICH | Kidney Chromophobe |
| KIRC | Kidney Renal Clear Cell Carcinoma |
| KIRP | Kidney Renal Papillary Cell Carcinoma |
| LAML | Acute Myeloid Leukemia |
| LGG | Brain Lower Grade Glioma |
| LIHC | Liver Hepatocellular Carcinoma |
| LncRNAs | Long Noncoding RNAs |
| LUAD | Lung Adenocarcinoma |
| LUSC | Lung Squamous Cell Carcinoma |
| MESO | Mesothelioma |
| OS | Overall Survival |
| OV | Ovarian Serous Cystadenocarcinoma |
| PAAD | Pancreatic Adenocarcinoma |
| PCPG | Pheochromocytoma and Paraganglioma |
| PEA | Pathway Enrichment Analysis |
| PFS | Progression-Free Survival |
| PRAD | Prostate Adenocarcinoma |
| PPP | Pentose Phosphate Pathway |
| READ | Rectum Adenocarcinoma |
| ROC | Receiver Operating Characteristic Curve |
| SARC | Sarcoma |
| SKCM | Skin Cutaneous Melanoma |
| STAD | Stomach Adenocarcinoma |
| TGCT | Testicular Germ Cell Tumors |
| THCA | Thyroid Carcinoma |
| THYM | Thymoma |
| TME | Tumor Microenvironment |
| UCEC | Uterine Corpus Endometrial Carcinoma |
| UCS | Uterine Carcinosarcoma |
| UVM | Uveal Melanoma |